Impacts of Cash Transfers on Child Neurodevelopment (Auxilio Brasil)
NCT ID: NCT05477901
Last Updated: 2025-06-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
450 participants
INTERVENTIONAL
2025-05-17
2028-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Aim 1: Determine the impact of high vs low cash transfers on children's exposure to adversities (ACEs) and neurodevelopment.
Aim 2: Determine the impact of cash transfers on children's inflammatory markers and HPA activity/cortisol.
Exploratory Aim: The investigators will explore (i) whether sex/gender of the children moderates the pathways in the above mediation model; and (ii) whether cash transfer-related effects persist 6 months post-RCT.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
SMART Africa (Strengthening Mental Health Research and Training)
NCT03081195
REstoring Mental Health Through COmmUnity-based Psychological Services in New York City
NCT04913766
Family Partner Navigation for Children
NCT03569449
Parent-Child Memory Study: Improving Future Thinking Among Mothers
NCT06145919
The Impact of Family CTI on Homeless Children
NCT00055081
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Aims and Hypotheses
Aim 1: Determine the impact of high vs low cash transfers on children's exposure to adversities (ACEs) and neurodevelopment. Eligible families will be those already enrolled in Brazil's national AB program. Relative to low cash transfers, children of mothers who received high cash transfers will have:
Hypothesis 1A (H1A) - \[ACEs\] fewer new onset ACEs over the 24-month course of the RCT; H1B - \[Neurodevelopment\] greater pre-vs-post RCT increases in prefrontal activation during an EF fMRI task (Simon task),10 increased connectivity within EF-related PFC/mesolimbic circuits (resting fMRI and diffusion MRI), and improvements in EF behaviors.
Aim 2: Determine the impact of cash transfers on children's inflammatory markers and HPA activity/cortisol.
Hypothesis 2A (H2A) - Relative to low cash transfers, children of mothers who received high cash transfers will have lower pre vs-post RCT levels of pro-inflammatory markers (e.g., CRP, Il-6, TNF-a; from blood draws) and hair cortisol (HPA activity over past 2-3 months).
Hypothesis 2B (H2B) - Inflammatory and HPA activity levels (H2A) will be lower in children with fewer new onset ACEs (i.e., new ACEs occurring during the 24-month RCT). H2C \[Mediation\] - The effects of high cash transfers on neurodevelopment (H1B) will be mediated by the impact of cash transfers on reducing new onset ACEs (H1A) and lower inflammation and HPA activity (H2A \& H2B), while taking into account covariates and three additional pathways (see A.9 And C.6.3).
Exploratory Aim: The investigators will explore (i) whether sex/gender of the children moderates the pathways in the above mediation model (H2C); and (ii) whether cash transfer-related effects - reducing new onset ACEs and symptoms (CBCL), and improved EF behavior - persist 6 months post-RCT.
Impact: Designed to decrease inequalities, AB is one of the largest social interventions in the world, yet its impact on child mental health is unknown. Our strategy, rather than relying on prohibitively expensive multi-site designs, proposes to generate evidence about the impact of AB on child neurodevelopmental outcomes by focusing on specific, well-supported mechanisms that may underlie mental illness risk. Our findings will have strong implications for tailoring the impact of cash transfer policies to maximize child mental health gains.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention
High supplemental transfer: $40 a month
Supplemental cash transfer
Supplemental cash transfer ($40/month)
Control
Low supplemental transfer: $2 a month
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Supplemental cash transfer
Supplemental cash transfer ($40/month)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Receiving AB cash transfers
3. Has at least two or more children ages 7- 10 years old at time of recruitment (up to 4 children per family)
4. Able to consent
Exclusion Criteria
Child:
Inclusion Criterion
1. Age 7-10 years old
2. Intellectual Disability
Exclusion Criterion
1. Does not reside in same household as the mother
2. Major Axis I disorder (e.g., Autism, Schizophrenia, Bipolar)
3. Severe Disability
4. MRI contradictions (index child only)
23 Years
45 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Mental Health (NIMH)
NIH
New York State Psychiatric Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Cristiane Duarte
Ruane Professor for the Implementation of Science for Child and Adolescent mental Health (in Psychiatry) at CUMC
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Cristiane Duarte, PhD
Role: PRINCIPAL_INVESTIGATOR
New York State Psychiatric Institute
Andrea Jackowsi, PhD
Role: PRINCIPAL_INVESTIGATOR
Federal University of São Paulo
Jonathan Posner, MD
Role: PRINCIPAL_INVESTIGATOR
Duke University
Tenneill Murray, MPH
Role: STUDY_DIRECTOR
New York State Psychiatric Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
New York State Psychiatric Institute
New York, New York, United States
UNIFESP
São Paulo, São Paulo, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB #8245
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.